» Articles » PMID: 23901270

Intravenous Magnetic Nanoparticle Cancer Hyperthermia

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2013 Aug 1
PMID 23901270
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Magnetic nanoparticles heated by an alternating magnetic field could be used to treat cancers, either alone or in combination with radiotherapy or chemotherapy. However, direct intratumoral injections suffer from tumor incongruence and invasiveness, typically leaving undertreated regions, which lead to cancer regrowth. Intravenous injection more faithfully loads tumors, but, so far, it has been difficult achieving the necessary concentration in tumors before systemic toxicity occurs. Here, we describe use of a magnetic nanoparticle that, with a well-tolerated intravenous dose, achieved a tumor concentration of 1.9 mg Fe/g tumor in a subcutaneous squamous cell carcinoma mouse model, with a tumor to non-tumor ratio > 16. With an applied field of 38 kA/m at 980 kHz, tumors could be heated to 60°C in 2 minutes, durably ablating them with millimeter (mm) precision, leaving surrounding tissue intact.

Citing Articles

DDS-type near-infrared light absorber enables deeper lesion treatment in laser photothermal therapy while avoiding damage to surrounding organs.

Takahashi M, Fujishiro J, Nomura S, Harada M, Hinoki A, Arake M Front Bioeng Biotechnol. 2024; 12:1444107.

PMID: 39211012 PMC: 11357940. DOI: 10.3389/fbioe.2024.1444107.


Manipulating the Crosstalk between Cancer and Immunosuppressive Cells with Phototherapeutic Gold-Nanohut for Reprogramming Tumor Microenvironment.

Cheng H, Lee W, Hsu F, Lai Y, Huang S, Lim C Adv Sci (Weinh). 2024; 11(32):e2404347.

PMID: 38923327 PMC: 11348132. DOI: 10.1002/advs.202404347.


Toxicity testing of indocyanine green and fluorodeoxyglucose conjugated iron oxide nanoparticles with and without exposure to a magnetic field.

Unak P, Hepton R, Harper M, Yasakci V, Pearce G, Russell S Asian J Nanosci Mater. 2024; 4(3):229-239.

PMID: 38192303 PMC: 10773553. DOI: 10.26655/AJNANOMAT.2021.3.5.


Near infrared-emitting multimodal nanosystem for in vitro magnetic hyperthermia of hepatocellular carcinoma and dual imaging of in vivo liver fibrosis.

Nazeer S, Saraswathy A, Nimi N, Santhakumar H, Radhakrishnapillai Suma P, Shenoy S Sci Rep. 2023; 13(1):12947.

PMID: 37558889 PMC: 10412632. DOI: 10.1038/s41598-023-40143-3.


X-Ray Nanothermometry of Nanoparticles in Tumor-Mimicking Tissues under Photothermia.

Lopez-Mendez R, Reguera J, Fromain A, Abu Serea E, Cespedes E, Teran F Adv Healthc Mater. 2023; 12(31):e2301863.

PMID: 37463675 PMC: 11469036. DOI: 10.1002/adhm.202301863.


References
1.
Seymour L . Passive tumor targeting of soluble macromolecules and drug conjugates. Crit Rev Ther Drug Carrier Syst. 1992; 9(2):135-87. View

2.
Le Renard P, Jordan O, Faes A, Petri-Fink A, Hofmann H, Rufenacht D . The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia. Biomaterials. 2009; 31(4):691-705. DOI: 10.1016/j.biomaterials.2009.09.091. View

3.
Kost J, Noecker R, Kunica E, Langer R . Magnetically controlled release systems: effect of polymer composition. J Biomed Mater Res. 1985; 19(8):935-40. DOI: 10.1002/jbm.820190805. View

4.
Lee J, Jang J, Choi J, Moon S, Noh S, Kim J . Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat Nanotechnol. 2011; 6(7):418-22. DOI: 10.1038/nnano.2011.95. View

5.
Hilger I, Hergt R, Kaiser W . Use of magnetic nanoparticle heating in the treatment of breast cancer. IEE Proc Nanobiotechnol. 2006; 152(1):33-9. DOI: 10.1049/ip-nbt:20055018. View